NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Gestational Response, Outcomes, and Weight After GLP-1 Use
Gestational Response, Outcomes, and Weight After GLP-1 Use

NCT07743567

RecruitingN/A

Sponsor: University of Kansas Medical Center

Conditions: Pregnant Individuals, Obesity & Overweight, Gestational Weight Gain

Countries: United States

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Eligibility overview

Sex: FEMALE

Age: 18 Years to 45 Years

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Adult women
* Less than or equal to 20 weeks gestation at first visit
* English speaking

Exclusion Criteria:

* \<18 years at time of initial visit
* Type 2 diabetes
* History of bariatric surgery
* Multiple gestation
* Cannot consent for themselves
* Cannot read and speak English
* Incarcerated
Locations (1)
  • Kansas City, Kansas, United States